Race-specific ERCC1 diplotypes frequency in patients with melanoma versus controls
| Caucasian melanoma cases vs Caucasian controls* | ||||
|---|---|---|---|---|
| Diplotype | Cases (%) | Controls (%) | OR (95% CI) | p Value |
| CCG-CCG | 16 (11) | 18 (20) | N/A | N/A |
| CCG-TGC | 50 (35) | 45 (49) | 1.25 (0.57 to 2.74) | 0.69 |
| TGC-TGC | 69 (49) | 27 (29) | 2.88 (1.28 to 6.45) | 0.012 |
| TGC-CGC | 5 (4) | 1 (1) | Not tested | N/A |
| CCG-CGC | 2 (1) | 1 (1) | Not tested | N/A |
*Complete genotyping data were not available in all patients.